INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE), PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS OF USE"

GENEVA, March 10 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2024/044473) for "RNAI AGENTS FOR INHIBITING EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE), PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE" on Aug 29, 2024. With publication no. WO/2025/049773, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NGAI, Michelle (Arrowhead Pharmaceuticals, Inc.502 S. Rosa RoadMadison, Wisconsin 53719), LIU, Feng (13336 Cultivate CourtVall...